Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Summaries for patients. Validity of models for predicting BRCA1 and BRCA2 mutations.

Annals of internal medicine - 2 Oct 2007

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Breast Neoplasms
Share to Cross-Sectional Studies
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Genetic Carrier Screening

Share to Models, Statistical

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 17909202
DOI: 10.7326/0003-4819-147-7-200710020-00001

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Summaries for patients. Validity of models for predicting BRCA1 and BRCA2 mutations.PMID 17909202Read ↗

Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.Semantic proximity Read ↗

Summaries for patients. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: U.S. Preventive Services Task Force recommendations.Semantic proximity Read ↗

BRCA1 and BRCA2: to test or not to test.Semantic proximity Read ↗

Validity of models for predicting BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

[China expert consensus on BRCA variant interpretation].Semantic proximity Read ↗

The role of testing for BRCA1 and BRCA2 mutations in cancer prevention.Semantic proximity Read ↗

Summaries for patients. The cost-effectiveness of preventive strategies for breast and ovarian cancer for women with BRCA1 or BRCA2 mutations.Semantic proximity Read ↗

Biomedicine. D-Day for BRCA2.Semantic proximity Read ↗

Summaries for patients. Do women with breast cancer overestimate their risk for cancer in the unaffected breast?Semantic proximity Read ↗

BRCA1 and BRCA2 variants of uncertain significance. Part two: medical management.Semantic proximity Read ↗

Cancer genetics: information sources for patients and families.Semantic proximity Read ↗

Variant classification changes over time in BRCA1 and BRCA2Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.